On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Bioactive Compounds and Antitumor Agents

TopicLeading institutions, researchers & key papers

Bioactive Compounds and Antitumor Agents is a topic indexed in ScholarIQ from OpenAlex.

What is known about Bioactive Compounds and Antitumor Agents?

ScholarIQrecord summary

This cluster of papers explores the role of quinones in toxicology and pharmacology, focusing on their cytotoxic effects, NAD(P)H:Quinone Oxidoreductase activity, apoptosis induction, and potential as anticancer and antimicrobial agents. The papers cover a wide range of topics including cellular pharmacology studies, mechanisms of cytotoxic action, pharmacological properties, and the synthesis and evaluation of quinone derivatives.

How many works does Bioactive Compounds and Antitumor Agents have?

ScholarIQindexed works

Bioactive Compounds and Antitumor Agents has 58 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Bioactive Compounds and Antitumor Agents?

ScholarIQopenalex

The OpenAlex for Bioactive Compounds and Antitumor Agents is on the source record.

What are the most-cited papers on Bioactive Compounds and Antitumor Agents?

ScholarIQmost cited works
Free radical formation by antitumor quinones
Garth Powis
Free Radical Biology and Medicine. 1989422 Citations
Plumbagin (5-Hydroxy-2-methyl-1,4-naphthoquinone) Induces Apoptosis and Cell Cycle Arrest in A549 Cells through p53 Accumulation via c-Jun NH2-Terminal Kinase-Mediated Phosphorylation at Serine 15 in Vitro and in Vivo
Ya‐Ling Hsu, Chien-Yu Cho, Po‐Lin Kuo, Yu‐Ting Huang, Chun‐Ching Lin
Journal of Pharmacology and Experimental Therapeutics. 2006208 Citations
Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice
Gi‐Su Oh, Hyungjin Kim, Jae-Hyuck Choi, AiHua Shen, Seong‐Kyu Choe, Anzani Karna, Seung‐Hoon Lee, Hyang-Jeong Jo, Sei‐Hoon Yang, Tae Hwan Kwak, Chul‐Ho Lee, Raekil Park, Hong‐Seob So
Kidney International. 2013148 CitationsOPEN ACCESS
Review of Shikonin and Derivatives: Isolation, Chemistry, Biosynthesis, Pharmacology and Toxicology
Snehlata Yadav, Ajay Sharma, Gulzar Ahmad Nayik, Raymond Cooper, Garima Bhardwaj, Harvinder Singh Sohal, Vishal Mutreja, Ramandeep Kaur, Franklin Oré Areche, Mohannad AlOudat, Ayaz Mukarram Shaikh, Béla Kovács, Abdelhakam Esmaeil Mohamed Ahmed
Frontiers in Pharmacology. 2022126 CitationsOPEN ACCESS
Induction of Apoptosis by Shikonin through Coordinative Modulation of the Bcl-2 Family, p27, and p53, Release of Cytochrome <i>c</i>, and Sequential Activation of Caspases in Human Colorectal Carcinoma Cells
Ping‐Chi Hsu, Yu‐Ting Huang, Mei‐Ling Tsai, Ying‐Jan Wang, Jen‐Kun Lin, Min‐Hsiung Pan
Journal of Agricultural and Food Chemistry. 2004108 Citations

Where is Bioactive Compounds and Antitumor Agents research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Bioactive Compounds and Antitumor Agents is open access?

ScholarIQopen access share
31%OPEN ACCESS
Gold
15%
Green
0%
Hybrid
8%
Bronze
8%
Closed
69%

Related on ScholarIQ

470M+ articles · 14-day free trial